Proteomics is critical for effective treatment of cancer, but still largely unknown. It seeks to identify small amounts of proteins or biomarkers in the blood serum of a patient, not only to diagnose the disease, but also to assess the evolution of the disease during therapy. This field of study is not as advanced as genomics and that although the genome of an organism is more or less constant, the proteome differs from one cell to another and from one moment to another. Experts say also that 80% of the proteins involved in cancer fall into the category of intrinsically disordered proteins (IDPs), unveiled a decade ago with the discovery of the genome, but whose function remains unknown.
Antiangiogenic therapy will also revolutionize future drugs. It is known that tumors need oxygen and nutrients from the organism to survive and grow. Anti-angiogenesis drugs “cut” this provision, so that the tumor eventually “die.” Several drugs have emerged such that not only benefit patients with cancer, but has also found its effectiveness to treat macular degeneration.
Stem cells are another important aspect in the fight against cancer. One of the characteristics of current treatments is that they target the cells ‘daughter’, reducing the tumor, while the long term can cause it to develop again, according to Gascón. The latest drugs attack the source, stem cell, and reduce the chances of relapse.
For all these advances be speeded up in time, it is essential that research results move as soon as possible to the daily life of patients. For this reason, it is fundamental the combination of basic and clinical research, ie, translational research, which seeks to transfer laboratory discoveries to patients as quickly as possible. www.christophermorganphotography.com
Global Health Access Program is a non-profit organization working to improve the well-being of communities in crisis, both locally and internationally, through the provision of health and public health services, capacity building, and resource
T-Systems ha sido la empresa elegida por el Ministerio de Ciencia e Innovación para explotar y gestionar sus servicios corporativos de proceso de datos, además de realizar la provisión, alojamiento y operación de su plataforma tecnológica en régimen de hosting dedicado y de sus sistemas corporativos.
You can link to this article on your web site using following code:
Website Code:
Forum Code:
Comments
We're looking for comments that are interesting, substantial or highly amusing. If your comments are excessively self-promotional (use your real name, no keywords please), obnoxious, or even worse, boring, you will be banned from commenting. Your comment must be related to the post. Please do not comment on how great or wonderful the post is. All comments are moderated and, if approved, will display in less than 24 hours.
